108 related articles for article (PubMed ID: 27838145)
1. Serum sortilin-derived propeptides concentrations are decreased in major depressive disorder patients.
Devader C; Roulot M; Moréno S; Minelli A; Bortolomasi M; Congiu C; Gennarelli M; Borsotto M; Heurteaux C; Mazella J
J Affect Disord; 2017 Jan; 208():443-447. PubMed ID: 27838145
[TBL] [Abstract][Full Text] [Related]
2. Investigation of serum levels of sortilin in response to antidepressant treatment.
Buttenschøn HN; Nielsen M; Glerup S; Mors O
Acta Neuropsychiatr; 2018 Apr; 30(2):111-116. PubMed ID: 28478778
[TBL] [Abstract][Full Text] [Related]
3. Electroconvulsive therapy exerts mainly acute molecular changes in serum of major depressive disorder patients.
Stelzhammer V; Guest PC; Rothermundt M; Sondermann C; Michael N; Schwarz E; Rahmoune H; Bahn S
Eur Neuropsychopharmacol; 2013 Oct; 23(10):1199-207. PubMed ID: 23183131
[TBL] [Abstract][Full Text] [Related]
4. Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design.
Mazella J; Pétrault O; Lucas G; Deval E; Béraud-Dufour S; Gandin C; El-Yacoubi M; Widmann C; Guyon A; Chevet E; Taouji S; Conductier G; Corinus A; Coppola T; Gobbi G; Nahon JL; Heurteaux C; Borsotto M
PLoS Biol; 2010 Apr; 8(4):e1000355. PubMed ID: 20405001
[TBL] [Abstract][Full Text] [Related]
5. The Involvement of Sortilin/NTSR3 in Depression as the Progenitor of Spadin and Its Role in the Membrane Expression of TREK-1.
Mazella J; Borsotto M; Heurteaux C
Front Pharmacol; 2018; 9():1541. PubMed ID: 30670975
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of blood proBDNF and its receptors in major depression.
Zhou L; Xiong J; Lim Y; Ruan Y; Huang C; Zhu Y; Zhong JH; Xiao Z; Zhou XF
J Affect Disord; 2013 Sep; 150(3):776-84. PubMed ID: 23537780
[TBL] [Abstract][Full Text] [Related]
7. Increased serum levels of sortilin-derived propeptide after electroconvulsive therapy in treatment-resistant depressed patients.
Roulot M; Minelli A; Bortolomasi M; Maffioletti E; Gennarelli M; Borsotto M; Heurteaux C; Mazella J
Neuropsychiatr Dis Treat; 2018; 14():2307-2312. PubMed ID: 30233189
[TBL] [Abstract][Full Text] [Related]
8. Sortilin derived propeptide regulation during adipocyte differentiation and inflammation.
Hivelin C; Mazella J; Coppola T
Biochem Biophys Res Commun; 2017 Jan; 482(1):87-92. PubMed ID: 27816451
[TBL] [Abstract][Full Text] [Related]
9. Increased serum levels of sortilin are associated with depression and correlated with BDNF and VEGF.
Buttenschøn HN; Demontis D; Kaas M; Elfving B; Mølgaard S; Gustafsen C; Kaerlev L; Petersen CM; Børglum AD; Mors O; Glerup S
Transl Psychiatry; 2015 Nov; 5(11):e677. PubMed ID: 26556286
[TBL] [Abstract][Full Text] [Related]
10. Discovery of serum protein biomarkers in drug-free patients with major depressive disorder.
Lee MY; Kim EY; Kim SH; Cho KC; Ha K; Kim KP; Ahn YM
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():60-8. PubMed ID: 27105922
[TBL] [Abstract][Full Text] [Related]
11. Low cocaine- and amphetamine-regulated transcript (CART) peptide levels in human cerebrospinal fluid of major depressive disorder (MDD) patients.
Yoon HS; Hattori K; Sasayama D; Kunugi H
J Affect Disord; 2018 May; 232():134-138. PubMed ID: 29486339
[TBL] [Abstract][Full Text] [Related]
12. Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (S) levels in medicated patients with major depressive disorder compared with controls.
Kurita H; Maeshima H; Kida S; Matsuzaka H; Shimano T; Nakano Y; Baba H; Suzuki T; Arai H
J Affect Disord; 2013 Apr; 146(2):205-12. PubMed ID: 23102506
[TBL] [Abstract][Full Text] [Related]
13. Plasma lipidomics reveals potential lipid markers of major depressive disorder.
Liu X; Li J; Zheng P; Zhao X; Zhou C; Hu C; Hou X; Wang H; Xie P; Xu G
Anal Bioanal Chem; 2016 Sep; 408(23):6497-507. PubMed ID: 27457104
[TBL] [Abstract][Full Text] [Related]
14. Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-naïve patients with major depressive disorder: An exploratory pilot case-control study.
Kuwano N; Kato TA; Setoyama D; Sato-Kasai M; Shimokawa N; Hayakawa K; Ohgidani M; Sagata N; Kubo H; Kishimoto J; Kang D; Kanba S
J Affect Disord; 2018 Apr; 231():74-82. PubMed ID: 29454180
[TBL] [Abstract][Full Text] [Related]
15. Decreased Prostaglandin D2 Levels in Major Depressive Disorder Are Associated with Depression-Like Behaviors.
Chu C; Wei H; Zhu W; Shen Y; Xu Q
Int J Neuropsychopharmacol; 2017 Sep; 20(9):731-739. PubMed ID: 28582515
[TBL] [Abstract][Full Text] [Related]
16. Reduced serum VGF levels were reversed by antidepressant treatment in depressed patients.
Jiang H; Chen S; Lu N; Yue Y; Yin Y; Zhang Y; Jiang W; Liang J; Yuan Y
World J Biol Psychiatry; 2017 Dec; 18(8):586-591. PubMed ID: 28635540
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of serum brain derived neurotrophic factor concentration in antidepressant naïve patients with first major depression episode.
Karlović D; Serretti A; Jevtović S; Vrkić N; Serić V; Peleš AM
J Psychiatr Res; 2013 Feb; 47(2):162-7. PubMed ID: 23102630
[TBL] [Abstract][Full Text] [Related]
18. Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort.
Lam RW; Milev R; Rotzinger S; Andreazza AC; Blier P; Brenner C; Daskalakis ZJ; Dharsee M; Downar J; Evans KR; Farzan F; Foster JA; Frey BN; Geraci J; Giacobbe P; Feilotter HE; Hall GB; Harkness KL; Hassel S; Ismail Z; Leri F; Liotti M; MacQueen GM; McAndrews MP; Minuzzi L; Müller DJ; Parikh SV; Placenza FM; Quilty LC; Ravindran AV; Salomons TV; Soares CN; Strother SC; Turecki G; Vaccarino AL; Vila-Rodriguez F; Kennedy SH;
BMC Psychiatry; 2016 Apr; 16():105. PubMed ID: 27084692
[TBL] [Abstract][Full Text] [Related]
19. Plasma dehydroepiandrosterone sulfate levels in patients with major depressive disorder correlate with remission during treatment with antidepressants.
Morita T; Senzaki K; Ishihara R; Umeda K; Iwata N; Nagai T; Hida H; Nabeshima T; Yukawa K; Ozaki N; Noda Y
Hum Psychopharmacol; 2014 May; 29(3):280-6. PubMed ID: 24911578
[TBL] [Abstract][Full Text] [Related]
20. Increased plasma levels of competing amino acids, rather than lowered plasma tryptophan levels, are associated with a non-response to treatment in major depression.
Ormstad H; Dahl J; Verkerk R; Andreassen OA; Maes M
Eur Neuropsychopharmacol; 2016 Aug; 26(8):1286-96. PubMed ID: 27237997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
